Regenerative Medicine Research
Building the future treatments of tomorrow.
Our Regenerative Medicine Research department is dedicated to unveiling the next discovery in this promising, emerging field. Primarily, the team is focused on furthering the science of engineering bio-artificial organs and tissues, understanding aging as a failure of stem cells, and identifying sex differences in cardiovascular disease and regenerative medicine treatments.
“Building hearts is not just about science. It’s about creating a team that gets it, lives it, and makes it real.”
Texas Heart Institute at Baylor College of Medicine is a leader in cardiovascular research including one of the most promising areas of medicine today, Regenerative Medicine. To lead the world in creating, translating, and delivering novel solutions for cardiovascular repair and regeneration, THI launched the Regenerative Medicine Research Department (RMR) in 2012.
The RMR team is a multi-cultural, diverse group of scientists, researchers and experts who utilize their depth of knowledge and unique backgrounds to contribute to the department’s areas of translational research.
The department’s laboratories include a College of American Pathology accredited Biorepository and Biospecimen Core Laboratory and the Organ Repair, Regeneration & Research Laboratory (OR3). Both laboratories are part of the Regenerative Medicine Research Department. Led by Camila Hochman Mendez, MSc., PhD, the Department is a place where scientists, engineers, physicians, veterinarians, and business managers can interact, collaborate and conduct promising research.
The RMR’s training programs include pre-and postdoctoral fellowships; competitive summer internships for high school and college-level students; and partnerships with various educational institutions in the Texas Medical Center. The department’s educational offerings emphasize the importance of an entrepreneurial spirit and mentorship, both in the lab setting and in navigating the complexities of research administration and funding.
Launched in 2012, the RMR is led by scientist and researcher Camila Hochman Mendez, MSc., PhD. Under her direction, the RMR helped to solidify THI as a leader in adult stem cell therapy, which is one of the most promising hopes for treating cardiovascular disease. Helping to shape and train the next generation of medical researchers is of critical importance to the RMR team.
Visit U.S. News & World Report
